This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Robarts Research Institute, The University of Western Ontario, Other. Active years: 1985-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ontario, CA (1985 - 1987)
- London, CA (2013 - 2018)
Company Filing History:
2 out of 13 
1 out of 160 
2 out of 834,513 Years Active: 1985-2018
Title: Innovations of John Barrett
Introduction
John Barrett is a notable inventor based in London, Canada, recognized for his contributions to therapeutic treatments, particularly in the field of cancer research. With a total of five patents to his name, Barrett has made significant strides in utilizing viral therapies for medical advancements.
Latest Patents
One of Barrett's latest patents involves the use of a combination of Myxoma virus and rapamycin for therapeutic treatment. This invention focuses on enhancing the ability of Myxoma virus to selectively infect cells that have a deficient innate anti-viral response, including those unresponsive to interferon. The combination can be utilized to treat diseases characterized by such cells, including various forms of cancer. Additionally, Barrett has developed Myxoma virus mutants that are deficient in specific proteins, which are also aimed at cancer treatment.
Career Highlights
Throughout his career, Barrett has worked with esteemed institutions, including the Robarts Research Institute. His innovative work has positioned him as a key figure in the field of viral therapies and cancer treatment.
Collaborations
Barrett has collaborated with notable colleagues such as Grant McFadden and Olaf Nigol, contributing to the advancement of research in his field.
Conclusion
John Barrett's innovative work in the therapeutic use of Myxoma virus showcases his commitment to advancing cancer treatment. His contributions continue to influence the medical research landscape significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile